7.07
-0.035(-0.49%)
Currency In USD
| Previous Close | 7.1 |
| Open | 7.05 |
| Day High | 7.14 |
| Day Low | 7 |
| 52-Week High | 8.9 |
| 52-Week Low | 3.54 |
| Volume | 25,190 |
| Average Volume | 144,969 |
| Market Cap | 172.32M |
| PE | -19.09 |
| EPS | -0.37 |
| Moving Average 50 Days | 7.29 |
| Moving Average 200 Days | 6.25 |
| Change | -0.04 |
If you invested $1000 in Journey Medical Corporation (DERM) since IPO date, it would be worth $711.11 as of September 30, 2025 at a share price of $7.04. Whereas If you bought $1000 worth of Journey Medical Corporation (DERM) shares 3 years ago, it would be worth $2,861.79 as of September 30, 2025 at a share price of $7.04.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Journey Medical Corporation to Participate in September 2025 Investor Conferences
GlobeNewswire Inc.
Sep 03, 2025 12:30 PM GMT
SCOTTSDALE, Ariz., Sept. 03, 2025 (GLOBE NEWSWIRE) -- Journey Medical Corporation (“Journey Medical” or “the Company”) (Nasdaq: DERM), a commercial-stage pharmaceutical company primarily focused on selling and marketing U.S. Food and Drug Administr
Journey Medical Corporation to Present at the Emerging Growth Conference
GlobeNewswire Inc.
Aug 18, 2025 12:30 PM GMT
SCOTTSDALE, Ariz., Aug. 18, 2025 (GLOBE NEWSWIRE) -- Journey Medical Corporation (Nasdaq: DERM) (“Journey Medical,” “the Company,” “we” or “our”), a commercial-stage pharmaceutical company primarily focused on selling and marketing FDA-approved pre
Journey Medical Corporation to Ring Nasdaq Stock Market Closing Bell on August 11
GlobeNewswire Inc.
Aug 07, 2025 12:30 PM GMT
SCOTTSDALE, Ariz., Aug. 07, 2025 (GLOBE NEWSWIRE) -- Journey Medical Corporation (Nasdaq: DERM) (“Journey Medical” or “the Company”, “we”, or “our”), a commercial-stage pharmaceutical company that primarily focuses on selling and marketing U.S. Foo